News

MedPage Today7h
Subcutaneous Lecanemab Maintenance Dosing for Alzheimer's Supported by New Data
TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of ...
Saudi Moments on MSN14h
Saudi Arabia Just Approved Its First Alzheimer's Drug
In a historic first, Saudi Arabia has approved Leqembi (lecanemab)—a breakthrough drug that targets early-stage ...